SEARCH
Media Coverage
Sorbent Dialysis Systems: An Expert Commentary by Stephen R. Ash, MD, FACP
MedScape, August 10, 2008
Sorbent dialysis is an innovative technology that has been used for over 35 years and is safe and proven. Through the years, sorbent dialysis therapy has evolved greatly, and recently a technologically advanced, simple-to-use sorbent system for home hemodialysis has been developed. The Allient Sorbent Hemodialysis System combines sorbent dialysis technology and a new blood pump with a unique, pressure-limited, 2-chamber design.
Venture Forum Highlights the 2008 M&A and IPO's in the Winner's Circle for Healthcare
MarketWatch, July 20, 2008
Fresenius Medical Care acquired Renal Solutions back in November 2007 for $200 million and is listed on the NYSE as FMS.
Renal Solutions adds two new members to medical advisory board
Renal Business Today, July 17, 2008
Renal Solutions Inc. said today that it has added Jose Diaz-Buxo, MD, FACP, and Todd Ing, MD, to its medical advisory board. Renal Solutions was acquired by Fresenius Medical Care in November 2007. Its sorbent therapy, known as the Allient Sorbent Hemodialysis System, uses six liters of drinking water to deliver one full dialysis treatment.
Dr. John Agar – A View on the Future of Dialysis
Home Dialysis Central, May 2008
Renal Solutions Inc. said today that it has added Jose Diaz-Buxo, MD, FACP, and Todd Ing, MD, to its medical advisory board. Renal Solutions was acquired by Fresenius Medical Care in November 2007. Its sorbent therapy, known as the Allient Sorbent Hemodialysis System, uses six liters of drinking water to deliver one full dialysis treatment. View video »
This is just a sampling of the many stories being printed about Renal Solutions...
SABIC Innovative Plastics' Lexan* Resin Meets Renal Solutions' Need for More Reliable Blood Pump, Increased Patient Care
SABIC Web site, January 30, 2008
Full Story:www.geplastics.com/gep/en/NewsRoom/NewsRoom/news_room.asp
Renal Solutions Announces Collaborative Agreement with Innovative Biotherapies and University of Michigan
BusinessWeek, August 27, 2007
Renal Solutions Inc. announced the signing of a collaborative agreement with Innovative BioTherapies Inc. (IBT) and the University of Michigan for development of a wearable renal replacement device. Through the terms of the agreement, Renal Solutions and David Humes, M.D. of IBT will explore the ways that sorbent therapy from Renal Solutions, which uses just six liters of potable tap water to deliver a full dialysis treatment, can be combined with the stem cell technologies of Innovative BioTherapies and the University of Michigan to ultimately develop a highly portable, wearable device for renal replacement.
Renal Solutions to collaborate with Innovative BioTherapies
NephrOnline, August 27, 2007
Renal Solutions Inc., the provider of Advanced Sorbent Therapyproducts and services for the treatment of chronic and acute renal failure, announces the signing of a collaborative agreement with Innovative BioTherapies, Inc. and the University of Michigan for development of a wearable renal replacement device.
Thinking small could be big for Renal
Pittsburgh Business Times, August 17, 2007
The future is getting smaller for a Cranberry Township company, which could bring some big changes in the way people with kidney failure are treated medically. Renal Solutions Inc. has reached a technology development agreement with a Michigan company to make a wearable artificial kidney, far smaller than the dialysis devices used today. The concept will be tested with an apartment refrigerator-size unit, which Renal Solutions plans to market in the fourth quarter of 2007.
Renal Solutions to launch revolutionary dialysis technology; hiring 15
POP City, August 28, 2007
The Cranberry Township provider of products and services to treat chronic and acute renal failure will place a revolutionary new technology on the market this October that will vastly improve the quality of life for kidney dialysis patients.
Renal Solutions Collaborates with Innovative BioTherapies
Renal Business Today, August 28, 2007
Renal Solutions’ sorbent therapy, known as the Allient Sorbent Hemodialysis System, uses six liters of potable tap water to deliver one full dialysis treatment. The agreement will also allow Innovative Biotherapies to evaluate the Allient System’s effectiveness in providing continuous dialytic therapy.
News
Pittsburgh Post-Gazette, August 27, 2007
Marshall-based Renal Solutions Inc. said it signed an agreement with Innovative BioTherapies Inc., of Ann Arbor, Mich., and the University of Michigan for development of a wearable artificial kidney.
Fresenius/Renal Solutions merger heats up the home dialysis market
Nephrology News and Issues, November 2007
by Mark E. Neumann, executive editor, Nephrology News & Issues
The announcement this week that Fresenius Medical Care AG would acquire fledging home hemodialysis machine maker Renal Solutions Inc. is another major step forward for advocates of home dialysis. The "little voices" in the renal community––doctors and patients alike—who have stubbornly clung to the dream that ALL patients can someday see home hemodialysis as a routine modality option may be seeing a light at the end of the tunnel.
German Firm Buying Renal Solutions
Pittsburgh Post-Gazette, November 30, 2007
Renal Solutions Inc., the Marshall-based provider of dialysis products, is being sold to a German firm that hopes to use its technology to develop wearable kidneys.